![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ANADYS PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK
ANADYS PHARMACEUTICALS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK
Anadys Pharmaceuticals, Inc. today announced that it has filed a preliminary
prospectus supplement to its shelf registration statement with the Securities
and Exchange Commission relating to a proposed underwritten public offering
of 4,000,000 shares of its common stock. It is currently anticipated that the
underwriters will be granted an over-allotment option for an additional 600,000
shares of common stock. All of the shares are being sold by Anadys Pharmaceuticals.
Yahoo
News
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct